NASP Speciality Pharmacy Podcast

Please visit our website to listen to prior podcast 1, 2 & 3 at https://lnkd.in/gsrjnv9P
 
The Specialty Pharmacy Healthcare eco-systems is becoming more efficient in the way they intake and treat patients, and patients are becoming more well-informed. Efficient and accurate communication among doctors, nurses, support staff, and patients has never been more important. With streams of information constantly flowing, there are ample opportunities for the chain of communication to break down and become a barrier to care—meaning delays in care for patients, and bottlenecks to clinician productivity. Specialty Pharmacies are more collaborative with their patient-engagement teams capabilities that strengthen this point of care. These healthcare solutions enable team members to drive key decisions with confidence, no matter where they are. With the freedom to focus less on ordering a specialty prescription, tracking down supplies, or logging data, patient care teams can focus more on what matters most: the patients. Therefore, specialty pharmacies differ, not by location, but by services offered and conditions treated. When treating chronic and rare conditions, those differences add up to make a big impact on patient success. The specialty pharmacies are improving drug treatment outcomes and breaking down the barriers that make patient access difficult. Patients facing complex, chronic, rare, or life-threatening conditions rely on the added support and resources a specialty pharmacy provides

The healthcare sectors are recognizing the value of innovative and effective strategies to address the challenges of managing specialty drugs, which treat complex, chronic or rare conditions and require special administration or handling. As a strategy to control the costs associated with managing a complex patient population, the market is turning to value-based contracting, which links reimbursement or payment for aproduct to positive clinical outcomes. These trends have paved the way for an increase in limited distribution drugs (LDDs), or therapies only made available to a small number of specialty pharmacies, to give manufacturers greater oversight and control over the quality of patient care and support. Specialty drugs are the future of medicine, but they require high-touch care coordination and concerted follow-up to ensure patients remain adherent and can manage potential side effects to realize the full value of therapy.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Participants: Mike Baldzicki (AscellaHealth), Kollet Koulianos (VP, NHF) and Dr. Ken Mankoski (Neurologist – MS)
Learn more about your ad choices. Visit megaphone.fm/adchoices

Participants and Roles:
·            Sheila Arquette, President & CEO, NASP -- Host
·            Ana Simonyan, PharmD, BCACP – Infectious Diseases -- Interviewer
·            Cody A. Chastain, MD – Infectious Diseases -- Responses
What you will learn:
·            The role of an integrated health system specialty pharmacist within the infectious disease clinic
·            A provider’s perspective of the benefits and challenges of integrating a pharmacist into a specialty clinic
·            How integrated health system specialty pharmacist affect specialty medication access, provider workload, and patient satisfaction
Learn more about your ad choices. Visit megaphone.fm/adchoices

Risk-based Care Can Drive Better Patient Adherence
Participants and Roles:          Sheila Arquette, President & CEO, NASP, Host/Interviewer                           
Purpose: Discuss how implementing risk-based care benefits patients and can improve their adherence rates
Ashleigh Burdette, MSN, RN, is the Sr. Director of Clinical Innovation with Biologics by McKesson. Ashleigh has been a Registered Nurse for nearly 15 years and holds a Master of Science in Nursing with a specialization in leadership and administration. She began her nursing career as an oncology nurse working in both bone marrow transplant and an outpatient clinic. In 2015, she joined Optum/United Health Group to focus on oncology patient support, utilization review, and clinical case management. In 2017, she joined Cardinal Health’s hub business and had the opportunity to lead both clinical operations and account management. Ashleigh joined Biologics by McKesson in 2020 to lead cross-functional collaboration to create customized patient management solutions that support the holistic needs of patients.
·            What is risked-based care, and how does it differ from “standardized care”?
·            What’s the methodology behind risked-based care?
·            Is the nurse-patient connection important? Why or why not?
·            What are some outcomes you’ve seen with this type of personalized level of care and support?
·            If someone wanted to implement this type of tailored support in their care setting, what are some of the essential components to keep in mind?
Contact the NASP: https://naspnet.org/about
Learn more about your ad choices. Visit megaphone.fm/adchoices

Topic: Package Performance Qualification (PPQ) Testing for URAC 4.0 Compliance & PBM Contracting
Participants and Roles:          
Sheila Arquette, President & CEO, NASP, Host/Interviewer
Katie Kraverath, Sr. Business Development Manager, Temptime Corporation
Bill Barrows, Program Director, Partner’s Healthcare Specialty Pharmacy
What you’ll learn:
Why it’s important to perform seasonal package performance qualification (PPQ) testing.
URAC and PBM requirements for PPQ Testing.
Processes and methods of testing, including third-party testing vs in-house testing.
An overview of changes to PPQ testing requirements per URAC’s new 4.0 version.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

All in for Specialty: How to Make Lasting Change in Patients’ Lives through Industry Standards and Guidance.”
Participants are: Lee Ann Stember, President & CEO of NCPDP
Sheila Arquette, President & CEO of National Association of Specialty Pharmacy
Sponsored by: UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack
https://www.ulticare.com/ultiguard-safe-pack/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

State of Specialty Pharmacy 2020 sponsored by LexisNexis. 
 Participants:               
Sheila Arquette, Executive Director, NASP, Host/Interviewer
Jill Regan, RPh, Director Relationship Management at LexisNexis Risk Solutions
John Heller, Senior Director of Sales LexisNexis Risk Solutions
Share results of LexisNexis Risk Solutions specialty pharmacy survey
LexisNexis Risk Solutions
July 23rd Webinar 
https://www.linkedin.com/company/lexisnexis-risk-solutions/ 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Title:There's No Going Back: Virtual Patient Support is Here to Stay
Participants and Roles:  Sheila Arquette, Executive Director, NASP
Melissa Kozak, RN, CRNI, CEO, Citus Health
Meagan Sampogna, COO, BioMatrix Specialty Pharmacy
Purpose: Discuss partnership and innovative solution to ensure business continuity for specialty patients during COVID-19 pandemic
This episode is sponsored by the University of California Irvine, UCI, Master of Science in Pharmacology, learn more: https://sites.uci.edu/mspharmacology/ 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

HealthCrowd Podcast
Participants:       
Sheila Arquette, Executive Director, NASP
Scott Sorensen, VP of Specialty Pharmacy, HealthCrowd
Introductions and brief bio
Sheila Arquette, Executive Director, National Association of Specialty Pharmacy
Scott Sorenson, VP of SP at HealthCrowd- 20+ experience working in SP- worked for Accredo, BioRx and Paragon
Scott, you have worked directly for specialty pharmacies for more than 20 years. HealthCrowd is quite a departure for you. Can you tell us a little bit about HealthCrowd and why did you join this organization?
Software solution
Innovative and intuitive
Automation of manual tasks that are customizable
The specialty pharmacy industry prides itself on providing high-touch care and services for patients with chronic and complex conditions. Why is automation a viable solution for specialty patients and the specialty industry?
Doesn’t not displace hi- touch
It’s an enhancement
Defers tasks that shouldn’t be burdensome to clinical staff
How and why does involving artificial intelligence (AI) plus human monitoring equal better outcomes?
AI is developing and learning quickly
still humans engineering and building the programs and people providing care
The AI just gives us an edge
How is the automation working so far?
Quite successfully.
multi-modalities of communications are used together or in sequence
don’t discriminate against those folks who have landlines
IVR is available
Can patients opt in or out of these services?
HIPAA PHI.
Safeguards-identifier such as DOB
Would they like to continue?
No- direct patient to SP personally
HIPAA PHI can be shared by 3 groups: Payors, Providers and Prescribers
What’s does the future look like and what are some of your immediate projects or goals?
De-silo healthcare
over 800 applications for cell and gene therapy submitted to the FDA
integration via communication will be the solution.
perfect patient communications platform
bridge that gap and an allow those in need, to have access to care
Sponsored by RxDestroyer 
https://www.rxdestroyer.com/pharmacypodcastnetwork/ 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices